Carrillo MRA

Language: Spanish
References: 15
Page: 27-32
PDF size: 537.30 Kb.

ABSTRACT

The structural image remains the main basis for the diagnosis of brain tumors. With the development of technology the magnetic resonance imaging improved diagnostic accuracy supported by functional methods such as diffusion, spectroscopy, perfusion and BOLD technique. The possibility of making a differential diagnosis between brain tumors and inflammatory processes, among The brain tumours themselves and to define the degree of malignancy, are the main goals of modern methods of image.

REFERENCES

1. Cha S. Update on brain tumor imaging: from anatomy to physiology. AJNR Am J Neuroradiol. 2006; 27 (3): 475-487.

2. Mascalchi M, Filippi M, Floris R, Fonda C, Gasparotti R, Villari N. Diffusion-weighted MR of the brain: methodology and clinical application. Radiol Med. 2005; 109 (3): 155-197.

3. Toh CH, Castillo M, Wong AM, Wei KC, Wong HF, Ng SH et al. Primary cerebral lymphoma and glioblastoma multiforme: differences in diffusion characteristics evaluated with diffusion tensor imaging. AJNR Am J Neuroradiol. 2008; 29 (3): 471-475.

4. Jellison BJ, Field AS, Medow J, Lazar M, Salamat MS, Alexander AL. Diffusion tensor imaging of cerebral white matter: a pictorial review of physics, fiber tract anatomy, and tumor imaging patterns. AJNR Am J Neuroradiol. 2004; 25 (3): 356-369.

5. Welker K, Boxerman J, Kalnin A, Kaufmann T, Shiroishi M, Wintermark M et al. ASFNR recommendations for clinical performance of MR dynamic susceptibility contrast perfusion imaging of the brain. AJNR Am J Neuroradiol. 2015; 36 (6): E41-E51.

6. Sugahara T, Korogi Y, Tomiguchi S, Shigematsu Y, Ikushima I, Kira T et al. Posttherapeutic intraaxial brain tumor: the value of perfusion-sensitive contrast-enhanced MR imaging for differentiating tumor recurrence from nonneoplastic contrast-enhancing tissue. AJNR Am J Neuroradiol. 2000; 21 (5): 901-909.

7. Pal D, Bhattacharyya A, Husain M, Prasad KN, Pandey CM, Gupta RK. In vivo proton MR spectroscopy evaluation of pyogenic brain abscesses: a report of 194 cases. AJNR Am J Neuroradiol. 2010; 31 (2): 360-366.

8. Majós C, Juliŕ-Sapé M, Alonso J, Serrallonga M, Aguilera C, Acebes JJ et al. Brain tumor classification by proton MR spectroscopy: comparison of diagnostic accuracy at short and long TE. AJNR Am J Neuroradiol. 2004; 25 (10): 1696-1704.

9. Scott WW, Koral K, Margraf LR, Klesse L, Sacco DJ, Weprin BE. Intracerebral schwannomas: a rare disease with varying natural history. J Neurosurg Pediatr. 2013; 12 (1): 6-12.

10. Panigrahy A, Krieger MD, González-Gómez I, Liu X, McComb JG, Finlay JL et al. Quantitative short echo time 1H-MR spectroscopy of untreated pediatric brain tumors: preoperative diagnosis and characterization. AJNR Am J Neuroradiol. 2006; 27 (3): 560-572.

11. Lu SS, Kim SJ, Kim HS, Choi CG, Lim YM, Kim EJ et al. Utility of proton MR spectroscopy for differentiating typical and atypical primary central nervous system lymphomas from tumefactive demyelinating lesions. AJNR Am J Neuroradiol. 2014; 35 (2): 270-277.

12. Mangalore S, Aryan S, Prasad Ch, Santosh V. Imaging characteristics of supratentorial ependymomas: Study on a large single institutional cohort with histopathological correlation. Asian J Neurosurg. 2015; 10 (4): 276-281.

13. Bezabeh T, Odlum O, Nason R, Kerr P, Sutherland D, Patel R et al. Prediction of treatment response in head and neck cancer by magnetic resonance spectroscopy. AJNR Am J Neuroradiol. 2005; 26 (8): 2108-2113.

14. Kim MJ, Holodny AI, Hou BL, Peck KK, Moskowitz CS, Bogomolny DL et al. The effect of prior surgery on blood oxygen level-dependent functional MR imaging in the preoperative assessment of brain tumors. AJNR Am J Neuroradiol. 2005; 26 (8): 1980-1985.

15. Pillai JJ. The evolution of clinical functional imaging during the past 2 decades and its current impact on neurosurgical planning. AJNR Am J Neuroradiol. 2010; 31 (2): 219-225.